Mission statement · Company scope
“Our mission is to discover, develop and commercialize a new class of RNA editing therapies capable of improving the lives of patients with rare and highly prevalent diseases.”
In use2026 – now1 sighting
First seenMar 2026Added
Last seenMar 2026Latest observation
Date created—Not published by the organization
Record
- Kind
- Mission
- Scope
- Company
- Style
- Impact (primary) · Innovation
- Leads with
- Change
- Best for
- Mission-driven · Climate & health
- Formula
- A world where [change]
- Tone
- Aspirational
- Length
- 28 words · reading grade 16.4
- Review status
- unreviewed · classifier rules-v0
- Quality score
- 0.74
- Record
- st_c004fb15a8746cdc
- Classification confidence
- 0.59
Sources1 sighting
SEC
SEC EDGAR filingsObserved 2026-03-12 · sec_sentence · 10-K · accession 0001193125-26-104156
View filing ↗0 to compareCompare